IMEXF (Imagin Medical) Shiller PE Ratio: (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Imagin Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Imagin Medical  (OTCPK:IMEXF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Imagin Medical Shiller PE Ratio Related Terms


Imagin Medical Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Shiller PE Ratio Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMEXF vs ABT, SYK, MDT: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Imagin Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imagin Medical Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Imagin Medical's Shiller PE Ratio falls into.



Imagin Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Imagin Medical's E10 for the quarter that ended in Jun. 2023 is calculated as:

For example, Imagin Medical's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.151/124.2033*124.2033
=0.151

Current CPI (Jun. 2023) = 124.2033.

Imagin Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201309 0.000 97.419 0.000
201312 -0.564 96.945 -0.723
201403 -0.540 98.604 -0.680
201406 -1.847 99.473 -2.306
201409 -6.721 99.394 -8.399
201412 -5.203 98.367 -6.570
201503 -0.476 99.789 -0.592
201506 0.000 100.500 0.000
201509 0.894 100.421 1.106
201512 -0.044 99.947 -0.055
201603 -0.605 101.054 -0.744
201606 -0.620 102.002 -0.755
201609 -0.239 101.765 -0.292
201612 -0.150 101.449 -0.184
201703 -0.149 102.634 -0.180
201706 -0.150 103.029 -0.181
201709 -0.163 103.345 -0.196
201712 -0.313 103.345 -0.376
201803 -0.464 105.004 -0.549
201806 -0.305 105.557 -0.359
201809 -0.307 105.636 -0.361
201812 -0.149 105.399 -0.176
201903 -0.150 106.979 -0.174
201906 -0.151 107.690 -0.174
201909 -0.181 107.611 -0.209
201912 -0.137 107.769 -0.158
202003 -0.193 107.927 -0.222
202006 -0.052 108.401 -0.060
202009 -0.053 108.164 -0.061
202012 -0.047 108.559 -0.054
202103 -0.207 110.298 -0.233
202106 -0.041 111.720 -0.046
202109 -0.710 112.905 -0.781
202112 -0.109 113.774 -0.119
202203 -0.095 117.646 -0.100
202206 0.367 120.806 0.377
202209 -0.352 120.648 -0.362
202212 0.001 120.964 0.001
202303 -0.058 122.702 -0.059
202306 0.151 124.203 0.151

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.